date,title,source
Oct-17-18,"NeuroMetrix, Inc. to Host Earnings Call",ACCESSWIRE
Oct-17-18,Edited Transcript of NURO earnings conference call or presentation 17-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-17-18,NeuroMetrix Reports Q3 2018 Financial Results,GlobeNewswire
Oct-17-18,"NeuroMetrix, Inc. to Host Earnings Call",ACCESSWIRE
Oct-18-18,NeuroMetrix Reports DPNCheck to be Featured at Upcoming 33rd Japan Society of Diabetic Complications Annual Meeting in Tokyo,GlobeNewswire
Oct-19-18,Edited Transcript of NURO earnings conference call or presentation 17-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-31-18,NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology,GlobeNewswire
Nov-15-18,NeuroMetrix Announces DPNCheck Collaboration Agreement with Fukuda Denshi for Japan Market,GlobeNewswire
Nov-15-18,"Report: Developing Opportunities within NeuroMetrix, Sunesis Pharmaceuticals, Siga Technologies, NexPoint Residential Trust, Frequency Electronics, and Horizon Technology Finance  Future Expectations, Projections Moving into 2018",GlobeNewswire
Nov-20-18,NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology,GlobeNewswire
Nov-28-18,"NeuroMetrix to Present at the LD Micro 11th Annual Main Event on December 5, 2018",GlobeNewswire
Dec-11-18,NeuroMetrix Reports Agreement with GSK Healthcare on 2019 Quell Joint Development Program and Modification to Strategic Collaboration,GlobeNewswire
Dec-12-18,"Is NeuroMetrix, Inc.s (NASDAQ:NURO) CEO Pay Fair?",Simply Wall St.
Dec-12-18,Today's Research Reports on Trending Tickers: NeuroMetrix and Moleculin,ACCESSWIRE
Dec-19-18,NeuroMetrix to Present at Upcoming Biotech Showcase 2019 In San Francisco,GlobeNewswire
Dec-26-18,Analyst: NeuroMetrix Benefits From Alternative Pain Management Trend,Benzinga
Dec-27-18,NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology,GlobeNewswire
Jan-07-19,"NeuroMetrix Adds Artificial Intelligence, Coaching and New Therapy Option to Quell 2.0 For Personalized Pain Relief",GlobeNewswire
Jan-08-19,Quell Named CES 2019 Innovation Awards Honoree,GlobeNewswire
Jan-15-19,"NeuroMetrix, Inc. Announces Fourth Quarter 2018 Financial Results Conference Call",GlobeNewswire
Jan-16-19,Quell Reports Successful CES 2019,GlobeNewswire
Jan-22-19,NeuroMetrix Reports Publication of Randomized Controlled Trial of Quell Wearable Pain Relief in Chronic Low Back Pain,GlobeNewswire
Jan-24-19,Edited Transcript of NURO earnings conference call or presentation 24-Jan-19 1:00pm GMT,Thomson Reuters StreetEvents
Jan-24-19,NeuroMetrix Reports Q4 and Full Year 2018 Financial Results,GlobeNewswire
Jan-28-19,"NeuroMetrix, Inc. (NASDAQ:NURO): A Fundamentally Attractive Investment",Simply Wall St.
Jan-28-19,Edited Transcript of NURO earnings conference call or presentation 24-Jan-19 1:00pm GMT,Thomson Reuters StreetEvents
Jan-29-19,NeuroMetrix Reports New Clinical Studies Published on DPNCheck,GlobeNewswire
Mar-07-19,"NeuroMetrix, Inc. (NASDAQ:NURO) Delivered A Weaker ROE Than Its Industry",Simply Wall St.
Apr-12-19,Earnings Preview: NeuroMetrix (NURO) Q1 Earnings Expected to Decline,Zacks
Apr-17-19,"NeuroMetrix, Inc. Announces Date for First Quarter 2019 Financial Results Conference Call",GlobeNewswire
Apr-18-19,Analysts Estimate NeuroMetrix (NURO) to Report a Decline in Earnings: What to Look Out for,Zacks
Apr-25-19,NeuroMetrix Reports Q1 2019 Financial Results,GlobeNewswire
Apr-25-19,"NeuroMetrix, Inc. to Host Earnings Call",ACCESSWIRE
